• Accueil
• mcv4
• CanSinoBIO announces approval for its MCV4 meningococcal vaccine Menhycia in China

CanSinoBIO announces approval for its MCV4 meningococcal vaccine Menhycia in China

4.5 (519) · € 19.99 · En Stock

China's CanSino in mRNA vaccine deal with AstraZeneca

Pfizer endorses CanSino's meningitis vaccine, giving Chinese

Sanofi Pasteur announces FDA approval of Menactra® - European

Articles about Tianjin CanSino Biologics

康希诺生物 CanSinoBIO

Articles about Tianjin CanSino Biologics

China's CanSino in mRNA vaccine deal with AstraZeneca

Convidecia - Wikipedia

CanSino and AstraZeneca form mRNA collab - BioProcess

康希诺生物 CanSinoBIO

Meningococcal immunizecanada

Pfizer endorses CanSino's meningitis vaccine, giving Chinese

China NMPA approves CanSinoBIO's Covid-19 vaccine as booster

IFV - Product Portfolio